Several factors, among which are genomic alterations and point mutations that lead to dysfunctional tumor suppressors, such as TP53 [117] or hyperactivated mitogenic and pro-survival molecules [118], contribute to the intrinsic predisposition of CLL cells to evade apoptosis [119]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.